Order Article Reprints

Song J-Y, Yoon J-G, Seo Y-B, Lee J, Eom J-S, Lee J-S, Choi W-S, Lee E-Y, Choi Y-A, Hyun H-J, et al. Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial. Journal of Clinical Medicine. 2021; 10(16):3545. https://doi.org/10.3390/jcm10163545

Song, Joon-Young, Jin-Gu Yoon, Yu-Bin Seo, Jacob Lee, Joong-Sik Eom, Jin-Soo Lee, Won-Suk Choi, Eun-Young Lee, Young-Ah Choi, Hak-Jun Hyun, and et al. 2021. "Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial" Journal of Clinical Medicine 10, no. 16: 3545. https://doi.org/10.3390/jcm10163545

Song, J.-Y., Yoon, J.-G., Seo, Y.-B., Lee, J., Eom, J.-S., Lee, J.-S., Choi, W.-S., Lee, E.-Y., Choi, Y.-A., Hyun, H.-J., Seong, H., Noh, J.-Y., Cheong, H.-J., & Kim, W.-J. (2021). Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial. Journal of Clinical Medicine, 10(16), 3545. https://doi.org/10.3390/jcm10163545